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1. Introduction 
Widely acknowledged to be the first person to make detailed studies of microscopic objects, 
the pioneering work of Antonie van Leeuwenhoek (1632-1723) provided the first glimpse of 
neurons when he observed sections of bovine optic nerves (van Zuylen, 1981). It was over a 
century later when the Italian scientist Camillo Golgi (1843-1926) developed la reazione nera 
(‘the black reaction’), later dubbed the Golgi stain or Golgi method, in 1873. This approach 
revealed a hitherto unseen world, one brought to light in stunning fashion in the decades 
that followed by Santiago Ramón y Cajal (1852-1934), who refined Golgi’s techniques and 
published numerous articles detailing the fine structure of the nervous system (Ramón y 
Cajal, 1995). The inescapable conclusion of this work - that the nervous system is composed 
of discrete cellular units, or neurons, that communicate with one another in a vast network - 
came to be known as ‘the neuron doctrine.’ It is from these initial findings that the 
sophisticated techniques available to today’s scientists are descended. 
One fundamental technical aspect of Ramón y Cajal’s work still holds true for many 
contemporary techniques; the fine structure of tissues and cells must be stabilized, or ‘fixed,’ 
before any further processing or visualization can be carried out. Fixation is a crucial step in 
staining cells or tissues of any type. This also applies to immunocytochemistry (ICC) – the 
process of labeling proteins within cells and tissues with the use of specific antibodies. 
Despite being initially restricted to purified serum samples of ill-defined specificity, the 
possibilities of this technique were immediately apparent. Provided a specific antibody is 
available, it is possible to visualize almost any protein within the cell. 
The development of the hybridoma technique to produce monoclonal antibodies against 
specific proteins or a specific amino acid sequence therein spurred a great increase in the 
practicality and popularity of immunostaining; theoretically limitless quantities of 
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antibodies of identical specificity could be generated using cell culture. This has doubtlessly 
accelerated the rate of discovery across all biomedical science disciplines. The information 
that can be gleaned from immunostaining is not restricted merely to whether a protein of 
interest is present within a given cell or tissue region. In principle, almost all of the 
processes that a protein goes through during its lifetime can be explored by ICC with the 
use of antibodies. This includes changes in the sub-cellular localization of the protein, 
developmental or pathological changes in expression and/or localization patterns, 
association or dissociation with other proteins, even post-translational modifications such as 
glycosylation and phosphorylation, as well as degradation at the end of a protein’s life 
(Misonou et al., 2006; Ogawa et al., 2008; Yus-Nájera et al., 2003). 
A yet more recent development was the exploitation of fluorescent proteins, which, when 
‘tagged’ onto any protein of interest, enable the visualization of proteins within live cells. 
This enabled the dynamics and the temporal characteristics of biological processes to be 
scrutinized like never before, and shed more light on the processes that enable cells such as 
neurons to establish and maintain homeostasis. Such approaches can be (and often are) used 
in conjunction with conventional immunostaining, both techniques complementing one 
another. The unique properties of fluorescent proteins have more recently been harnessed in 
another way, in order to explore associations between proteins at a truly molecular level. 
Only when two proteins with appropriate fluorescent protein tags are in extremely close 
proximity to one another can the process of fluorescent resonance energy transfer (FRET) 
occur, a process that today’s scientists exploit in order to explore protein-protein 
interactions.  
These techniques have allowed us to peer deeper into the complexities of cells than ever 
before, and still doubtlessly have a great deal to tell us. It is these techniques, their 
optimization, applications and limitations, which we intend to describe here by focusing on 
ion channel proteins expressed in cell lines and neurons as our principal examples. Ion 
channels are a functionally diverse group of proteins with a multitude of closely-related 
subfamily members. Furthermore, the extensive control over subcellular localization, 
protein-protein interaction and post-translational modifications these proteins undergo 
means that they represent both the difficulties and fascinating insights that ICC has to offer. 
2. Cell fixation  
It is self-evident that one of the key aims of ICC is to label subcellular components in a way 
that most closely reflects their native confirmation within the cell. This enables investigators 
to make judgments based on their data that are likely to be in accordance with cells and 
tissues in their live state. This means that all metabolic processes must be terminated as 
quickly as possible, whilst preserving the morphology of cells and organelles, and the 
distribution of proteins therein. However, fixation that is too extensive may begin to alter 
the structure of proteins from their native confirmation so significantly that antibodies are 
no longer able to bind to their target sequence in the antigen/protein (epitope), resulting in 
decreased staining intensity and possibly an increase in the background ‘noise’ of the stain. 
On the other hand, incomplete fixation will not halt proteolytic and other enzymatic and 
metabolic processes sufficiently quickly. This can also reduce staining intensity and 
introduce abnormal staining patterns or fixation artifacts (Spector & Goldman, 2006). Of the 
main fixatives generally employed in ICC (glutaraldehyde, paraformaldehyde, 
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methanol/acetone), paraformaldehyde is the most widely used, since it provides a good 
balance of thorough and rapid fixation of tissue/cells to preserve cell organelle morphology 
and the target epitope(s).   
Glutaraldehyde is usually employed in electron microscopy studies because of its ability to 
preserve ultrastructural detail. However, the slow rate of cellular penetration and the 
extensive cross-linking that results from glutaraldehyde fixation make it a poor choice for 
most ICC studies, since this can impede antibody penetration and binding, thereby reducing 
specific signal and increasing background fluorescence. 
Much more rapid fixation is possible with the use of cold acetone or methanol, and as a 
result they are employed more frequently in ICC than glutaraldehyde. However, they still 
present several potential problems for ICC studies. Methanol treatment leads to 
precipitation of proteins, which can disrupt the localization and/or detectability of certain 
antigens, and the permeabilization of cells that results from the solubilization of lipids may 
also result in the loss of more soluble antigens. Therefore, acetone or methanol fixation is 
usually employed only when rapid fixation and simultaneous permeabilization of cells is 
required, or for studies on particularly resilient antigens (e.g. the actin cytoskeleton, 
microtubules, intermediate filament networks (Spector & Goldman, 2006)). 
Paraformaldehyde (or, to be more accurate, simply ‘formaldehyde,’ once present in its 
monomeric form in solution) is less effective than glutaraldehyde at cross-linking proteins 
by forming methylene bridges, meaning that while fixation and ultrastructural preservation 
aren’t as robust as with glutaraldehyde, antigenicity is more likely to be maintained. Like 
glutaraldehyde, paraformaldehyde does not permeabilize cells, meaning that, unless surface 
or extracellular antigens are being detected, subsequent permeabilization will be necessary. 
It is also for this reason that preparing fresh solutions of formaldehyde from 
paraformaldehyde is recommended, so that the methanol that is often present in many 
commercially available formaldehyde solutions does not inadvertently permeabilize the 
cells. For fixation of cells, formaldehyde is typically used at 3-4% in phosphate-buffered 
saline, pH 7.4, and applied at room temperature for 15 minutes, or at 4°C for 30 minutes. 
The water in which the paraformaldehyde is dissolved must first be heated to 
approximately 60°C and subsequently brought to alkaline pH (approximately 10.5) for the 
paraformaldehyde to dissolve. Once the components of the phosphate buffer have been 
added, the pH must then be adjusted to 7.4 with hydrochloric acid. Opinions vary regarding 
the shelf life of formaldehyde prepared in this way; some generate small batches that are 
used within 24 hours, others generate larger quantities that are stored at 4°C for several 
months (Williams, 1997).  
Several additives may also be included in the formaldehyde solution that can better 
preserve cell structure, the inclusion of 4% sucrose being a prime example. It is thought that 
the inclusion of a non-electrolyte such as sucrose inhibits the extraction of intracellular 
components during fixation, a factor that can improve staining quality, particularly for 
membrane proteins, and especially in cells such as neurons, with a large surface area-to-
volume ratio. Similar effects have also been reported with the inclusion of 1-3mM CaCl2 
and/or MgCl2 in the fixative. 
If the cross-linking that formaldehyde introduces does preclude the binding of antibodies to 
their target, some cross-links can be broken, restoring more of the native conformation to 
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cellular structures. Such processes are referred to as antigen retrieval, and are mainly 
enzyme or heat-mediated. Incubation of specimens at temperatures of approximately 60°C 
in an antigen retrieval buffer (most commonly sodium citrate, pH 6.0) is performed for 
several minutes, although the time needed for effective retrieval varies widely from antigen 
to antigen and must be determined experimentally (Daneshtalab, 2010; Shi et al., 2001). In 
short, antigen retrieval on cultured cells should only be considered as a last resort – if at all 
possible, an antibody that has been validated for use specifically in ICC (and for the antigen 
in the species of origin) should be used in order to minimize the chances of requiring any 
antigen retrieval steps. 
3. Blocking and permeabilization  
Following fixation, but prior to incubation with primary antibodies, cells must be 
permeabilized in order to allow antibodies to penetrate cellular membranes. Several 
different detergents are often employed to this end, including Triton X-100, Tween 20 and 
saponin. They are usually used at concentrations between 0.1 to 0.5%, and are either 
administered as a separate step prior to blocking, or co-administered with the blocking 
step. Some protocols specify that a small amount of detergent be kept in the buffers 
throughout blocking and antibody incubation steps, in order to prevent non-specific 
interaction of antibodies in different cellular compartments. There are certain exceptions 
where cells need not be permeabilized; those situations where an antibody is raised 
against an extracellular region of a membrane protein for instance, or perhaps a 
component of the extracellular matrix, do not require detergent treatment. In fact, such 
antibodies can be used to gain insight into the level of surface expression of a particular 
protein - relative to the total cellular expression - and in studies of trafficking to and from 
the plasma membrane. 
Whether or not it occurs in tandem with solubilization, samples must also be ‘blocked,’ 
the process by which all potential antibody binding sites (or ‘reactive sites’) in the sample 
are blocked by incubation with a protein with no specific affinity. If this is not carried out, 
the level of non-specific binding of antibodies to ‘off-target’ sites will increase 
dramatically, elevating background signal. For immunostaining of cultured cells, there are 
two main categories of blocking agent. Normal serum is often used, particularly because it 
carries immunoglobulins that will bind to reactive sites throughout the sample, reducing 
the likelihood that the primary antibody will do the same when it is introduced. 
Optimally, the serum should be sourced from the animal in which the secondary antibody 
was raised (i.e., when using a goat anti-mouse IgG2a secondary, goat serum should be 
used). This should further reduce the possibility of excessive binding of primary or 
secondary antibodies to off-target sites, ensuring a clean, specific staining signal. Bovine 
serum albumin or nonfat dry milk are also often used. Again, the principle is similar; the 
primary antibody ‘competes’ against the proteins in the blocking solution for binding to 
all available epitopes. Theoretically, the affinity of the antibody for its target is far greater 
than the affinity of the blocking protein for that same region. Furthermore, the affinity of 
the antibody for all other, off-target epitopes should, on average, be equal to or lower than 
that of the blocking protein. The result should be that the antibody binds to only those 
regions against which it was designed, generating the desired high signal-to-noise  
ratio. 
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4. Antibodies: their generation, properties and criteria for selection in 
immunocytochemistry  
4.1 Polyclonal versus monoclonal antibodies 
Polyclonal antibodies were the original approach to detect an antigen of interest – a process 
that involved little more than multiple injections into a suitable host animal of the antigen 
along with an adjuvant to stimulate the immune response. The animal’s B-lymphocyte 
response results in the secretion of multiple distinct antibody molecules (or clones) into the 
bloodstream, each specific for a single epitope on the antigen. This serum could then be 
purified and used to stain cells for the antigen of interest. This technique represented a huge 
leap forward from histological stains (such as the Nissl stain, hematoxylin-eosin, silver 
nitrate-based methods etc.), but there is a crucial weakness. The availability of the specific 
antiserum is limited to the lifespan of the animal – after the last batch the animal produced 
is exhausted, the antibody is virtually lost, with no guarantee that any subsequent 
immunizations of further animals would produce an antiserum of similar titer and 
specificity. 
In the mid-1970’s came the development of monoclonal antibodies. In this system, the first 
steps are identical to those involved in polyclonal antibody production; an animal (in this 
instance, usually a mouse, but more recently rabbits too) is immunized with the antigen, 
perhaps several times, until it is confirmed that there are antigen-specific antibodies in the 
serum. The spleen is then removed and the splenocytes fused with a myeloma cell line 
(which is immortal, but doesn’t produce antibodies). The resultant hybridomas are selected 
for by culturing in HAT (hypoxanthine-aminopterin-thymidine) medium. The combination 
of inhibitors and nucleotide precursors in HAT medium cause the myeloma cells to die 
because they are unable to synthesize DNA (due to their lack of functional thymidine kinase 
or hypoxanthine-guanine phosphoribosyltransferase). The unfused B-cells are of course still 
mortal and will eventually die after a limited number of divisions, leaving a relatively pure 
population of hybridomas, each one secreting its own specific antibody clone, which can be 
further subdivided and tested until a single well-performing clone is isolated. The 
theoretically limitless production of this antibody – as long as the hybridoma is maintained 
– is key to the phenomenal success of monoclonal antibodies. The antibody produced from 
this hybridoma or any of its descendants will remain identical in every respect; the value of 
the reproducible specificity and performance of antibodies generated in this way cannot be 
overstated (Cambrioso & Keating, 1992). 
That said, polyclonal antibodies still have some advantages in ICC. Since polyclonal 
antibodies contain many different clones directed against the same antigen, it is possible 
that they have a greater tolerance for detecting variants of a particular protein of interest, i.e. 
paralogs, homologs, or proteins with interactions that ‘mask’ some epitopes. This is 
something of a double-edged sword, as it can introduce cross-reactivity into the background 
of a particular stain, but polyclonals are just as likely to be able to detect and bind despite 
subtle variations in an antigen that a monoclonal, with specificity for just a single epitope, 
cannot. 
4.2 The importance of validating your antibody 
One of the major difficulties of immunological detection of proteins of interest is non-
specific binding of the antibody, which causes misinterpretation of the obtained results. 
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Ensuring the lack of non-specific binding of the antibody is even more important when only 
a low copy number of the antigen of interest is present, since even a low cross-reactivity 
with a more abundant protein in these situations could lead to misinterpretation of the 
results. For example, just a few thousand copies of an ion channel may still have a 
significant functional contribution to the membrane properties of the cell, but this level of 
expression may be difficult to detect using ICC and this low level of detection will be 
overwhelmed when the antibody binds non-specifically to another, more abundantly 
expressed protein. Testing the antibody specificity is also more important when the antigen 
to which the antibody was raised shows strong sequence similarity with related proteins. 
For example, to visualize ion channels at the plasma membrane using ICC, only the small 
extracellular parts of the ion channel are available for antibody binding. Such extracellular 
loops are relatively well-conserved between channels belonging to the same subfamily 
which makes it more difficult to find or generate a unique subunit-specific antibody. 
Due to non-specific binding of antibodies, it is important to perform appropriate controls of 
the antibody’s specificity in order to obtain reliable staining. The most reliable way to test an 
antibody’s specificity is to use tissue samples from organisms which lack the specific 
protein(s) of interest by knocking-out the corresponding genes; all staining that remains in 
such tissue samples represents non-specific binding of the antibody (Rhodes & Trimmer, 
2006; Saper, 2005). However, there is not a knock-out organism available for every protein of 
interest, and generating such an organism takes a lot of knowledge, time and money which, 
if it is solely to test the specificity of an antibody, is impractical. Another way to test the 
antibody’s specificity is by knocking-down the protein of interest in cells that express this 
protein endogenously using the RNA-interference (RNAi) method. However, with the 
RNAi approach the majority, but not all copies of the protein of interest are eliminated – 
depending on the turn-over rate – which makes it difficult to discriminate whether 
detectable staining is originating from residual protein of interest or non-specific binding of 
the antibody to other proteins. In addition, RNAi also requires specialized knowledge and 
appropriate controls in order to be performed correctly. The specificity of an antibody can 
also be tested by pre-incubating the antibody with the antigen or immunizing peptide. In 
this way it can be determined whether at least a part of the detected staining is originating 
from the specific binding of the antibody to the protein of interest. However, there is always 
the possibility that the pre-incubation of the antibody with its antigen or immunizing 
peptide itself cause a reduction in the staining intensity without being related to the 
antibody specificity. To determine whether an antibody discriminates between highly-
conserved proteins, such as the different members of a voltage-gated potassium (Kv) 
channel subfamily, different members of this subfamily could be expressed separately in 
heterologous expression systems and tested for antibody binding. In this case, non-
transfected cells must also be tested for antibody binding. This ensures that the antibody is 
not binding to endogenous cellular proteins and prevents misinterpretation of the results. 
4.3 Appropriate use of antibodies 
Depending on their source and prior purification (if any), an antibody solution may be in 
one of several different forms. Polyclonal antibodies, if they haven’t already been purified 
may be supplied as whole serum, which needs to be diluted prior to use in the same way as 
purified antibody, albeit to a much lesser extent. If monoclonal antibodies are not purified, 
they may be provided as a tissue culture supernatant, literally the tissue culture medium in 
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which the relevant hybridoma was grown, and into which the monoclonal antibody was 
secreted. These preparations haven’t been affinity purified, which makes them less time-
consuming and costly to generate, but a larger volume has to be used relative to the 
blocking solution than if the antibody is purified. The volume of antibody required to 
achieve good staining in these situations can sometimes be very high relative to the total 
volume of antibody and diluent, a problem that can sometimes significantly reduce the 
availability of blocking agent in the solution, potentially compromising binding specificity 
and increasing background noise. As a precaution, any dilutions of antibodies that will 
reduce the final concentration of blocking agent by more than 25% should instead be made 
with a more concentrated blocking agent to maintain a sufficient final concentration and 
blocking capacity. 
As each antibody generated varies, even if it is targeted against the same epitope, it is 
difficult to determine with any certainty what concentration of a particular antibody will 
yield the most satisfactory results. Typically, a good starting range for an antibody on 
cultured cells is 1-2µg/ml, although this varies significantly, depending on the affinity of the 
antibody for its epitope. This final concentration may represent a dilution of only 1:5 or 1:10 
of whole serum or tissue culture supernatant, but 1:500 or 1:1000 of a purified antibody. The 
best way to establish good staining with a new antibody is to perform a dilution series 
across a broad range. This should make it possible to find a dilution that provides optimal 
signal of the antigen of interest with minimal background. It should also be noted that once 
diluted to their working concentration, the stability of antibodies is reduced (this principle 
of maintaining stability of proteins by keeping the total protein concentration of a sample 
high is the rationale behind supplementing many purified antibody samples with additional 
protein, usually bovine serum albumin). It is for this reason that solutions of antibodies 
diluted to their working concentrations should not be kept for more than 24-48 hours. 
4.4 Storage of antibodies 
Antibodies are of course complex protein molecules, and should be treated in the same way 
as any other protein sample in order to minimize its degradation and preserve its biological 
activity. In the majority of cases, primary antibodies should be split into small volume 
aliquots and stored at -20°C, whether the solution contains an antifreeze agent such as 
glycerol or not. This will reduce the number of freeze/thaw cycles the antibody receives, as 
well as minimizing the risk of contamination. However, there are several important 
exceptions to this rule: although rare, monoclonal antibodies of the IgG3 isotype are 
especially vulnerable to forming precipitates upon thawing and should be stored at 4°C. 
Furthermore, antibodies conjugated to enzymes should also be stored at 4°C to maintain 
enzyme activity. Sodium azide is often included in antibody solutions as an antimicrobial 
agent. If desired, it can be added to solutions that don’t already contain it to a final 
concentration of 0.01-0.05%. However, care must be taken that it is not used with secondary 
antibodies conjugated to horseradish peroxidase (HRP), as sodium azide is a potent 
inhibitor of HRP activity (Ortiz de Montellano et al., 1988). 
4.5 Secondary antibodies: fluorescent versus enzyme-based methods 
Secondary antibodies are used to indirectly detect an antigen to which the primary antibody 
has bound. Since the vast majority of commercial antibodies are derived from a small 
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number of species, a wide, versatile range of secondary antibodies are available to detect 
any primary antibody. An additional advantage of using secondary antibodies is that 
several secondary antibody molecules can bind to each primary antibody molecule, 
amplifying the signal several-fold versus a directly conjugated antibody (see section 4.6.3). 
Broadly speaking, there are two classes of covalently-bound tag found on secondary 
antibodies – fluorophores and enzymes – of which the fluorophore family is more diverse 
and more widely used in ICC.  
Since secondary antibodies are essentially generated by immunizing one species of animal 
with the antibody from another, they follow the standard ‘host anti-target-tag’ nomenclature 
i.e., goat anti-mouse IgG-Alexa Fluor 488. Understanding and paying attention to this 
nomenclature can also help to avoid a very common pitfall when performing stainings with 
multiple primary antibodies. Since goats are widely used to generate secondary antibodies, 
any staining that happens to use a goat polyclonal primary antibody must not employ any 
secondary antibodies of goat origin, since any anti-goat secondary antibody applied to the 
sample will also bind secondary antibodies of goat origin present in the sample, since they 
are also goat IgG molecules. This will generate unexpected labeling patterns and 
confounding results. This can be avoided by using secondary antibodies from another 
species (e.g. donkey) in these cases. 
In addition to secondaries with class-wide specificity, there are also isotype-specific 
secondary antibodies, which, depending on the extent of their purification, should only 
recognize one particular isotype; mouse IgG2a, for example. Affinity purification (passing 
the secondary through a column containing off-target immunoglobulins) and cross-
adsorption (effectively filtering the secondary antibody through serum proteins from other 
species to remove virtually all traces of non-specific binding) are used to generate so-called 
‘highly cross-adsorbed’ secondaries. These allow the end user to simultaneously label 
several different antigens in the same specimen, primary antibodies permitting. For 
instance, using isotype-specific secondary antibodies, each labeled with a fluorophore of a 
different emission wavelength, it is routinely possible to visualize labeling of a rabbit 
polyclonal, a mouse monoclonal IgG1, IgG2a and IgG2b antibodies, all within the same 
sample. This of course assumes that the appropriate excitation source and filters are 
available on the microscope (see section 5). 
The number of fluorophore wavelengths available easily exceeds the total number of 
widely-used antibody classes and subtypes. Commercial suppliers have their own 
proprietary versions, but the emission wavelengths generally fall into 5 main classes: blue 
fluorophores (e.g. Alexa Fluor/DyLight 350, 405, AMCA), green (Alexa Fluor/DyLight 488, 
FITC), yellow-red (DyLight 550, Alexa Fluor 546, 555, Cy3, TRITC), red (DyLight 633, 650, 
Alexa Fluor 633, 647, Cy5) and near-IR-infrared (Dylight 680, 750, 800, Alexa Fluor 680, 750, 
Cy5.5). 
The principles of isotype specificity also apply to those secondary antibodies conjugated to 
enzymes (typically horseradish peroxidase (HRP) or alkaline phosphatase (AP) and, more 
rarely, glucose oxidase), but the detection of antibody binding differs significantly from the 
fluorescent conjugate approach. In this scenario, a secondary antibody conjugated to HRP or 
AP (or perhaps a biotinylated secondary binding an avidin-HRP or avidin-AP conjugate) is 
incubated with a substrate solution which is converted into a colored precipitate in the 
immediate vicinity of the enzyme. These additional recruitment and binding stages mean 
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that the amplification of the initial signal is greater than with direct conjugates, offering 
much greater sensitivity. In addition, the precipitates generated from the substrate solutions 
(or ‘chromogens’) are observable with a conventional visible light microscope, eliminating 
the need for fluorescence light sources and optics. In addition, the insoluble deposits left 
behind from an enzyme’s activity should theoretically preclude any interaction of 
subsequent primary antibodies with that region, meaning that multiple primary antibodies 
from the same species could be detected, albeit sequentially, in the same specimen (Grube, 
2004). There are, however, also some disadvantages to this approach when compared to 
fluorescence-based strategies. Multiple labeling is possible, since several different substrates 
are available for each enzyme – red, brown/black and purple colors are possible with the 
NovaRED, DAB/Ni and VIP substrates for HRP, respectively, as are red, blue and 
blue/violet with the Red, Blue and BCIP/NBT substrates for AP, but if versatility and 
routine triple or quadruple labeling are required, fluorescence becomes the more viable 
option. The additional incubation steps that the enzyme conjugate approach requires take 
substantially more time than incubation with a fluorophore-conjugated secondary, and 
there is also the issue (specifically with HRP conjugates) of endogenous peroxidases in cells 
and tissues which, unless ‘quenched’ by prior incubation with hydrogen peroxide, may 
contribute to high levels of background staining. 
4.6 Kits and alternative strategies 
Despite the vast array of antibodies now available, it is highly likely that investigators will 
eventually encounter a scenario where the staining that needs to be carried out doesn’t 
appear to be compatible with the antibodies that are available. Detailed in this section are 
three approaches that can be used to circumvent some of these issues. 
4.6.1 ‘Mouse-on-mouse’ kits 
Multiple antibody stainings are a common requirement in studies involving ICC, whether it 
is used to discover potential interactions between two or more proteins, to label different 
cell subtypes in a mixed population, or merely to confirm the specificity of one antibody 
relative to another. All too often, however, the popularity of mouse monoclonal antibodies 
and the mouse as a model organism means that investigators will be left with no option but 
to attempt to stain cells of mouse origin with a mouse antibody. This can generate problems 
when secondary detection methods are used, since a goat anti-mouse IgG secondary 
antibody may fail to discriminate between the primary antibody IgG molecules and the 
endogenous IgG molecules expressed by the cells, increasing non-specific staining. There 
are several commercial kits available designed for these situations that use proprietary 
blocking solutions or conjugation steps to reduce or eliminate this background staining. 
However, these so-called ‘mouse-on-mouse’ kits are of little use when multiple antibodies of 
the same isotype need to be applied to the same sample, an obstacle that the following two 
alternative strategies can overcome. 
4.6.2 Zenon labeling 
In many ways, mouse monoclonal antibody technology has become a victim of its own 
success; frequently there aren’t antibodies available in distinct species or isotypes, which 
precludes specific detection of each signal. Zenon labeling, however, can overcome these 
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limitations. In this system, the target specific antibody is incubated with fluorophore-
conjugated Fab fragments specific for the Fc region of the antibody to be labeled (e.g. anti-
mouse IgG1 Fab fragments conjugated to Alexa Fluor 488). Following a further incubation 
with a non-specific IgG (to complex any remaining unbound Fab fragments), the labeled 
antibody can now be applied to cells in tandem with any other primary antibodies, 
irrespective of their isotype. The approach is similar in principle to incubating an antibody 
with a covalently reactive label (and generates fluorescence comparable to that seen with 
such direct conjugates; see section 4.6.3), however, it affords greater flexibility in terms of 
switching fluorophore conjugates and no affinity purification of the sample is required post-
conjugation (van Duijnhoven et al., 2005). 
4.6.3 Direct conjugates 
When multiple antibodies of the same isotype or species need to be applied to cells, another 
means of solving the issue is to switch to a directly conjugated version of the antibody, 
which are often commercially available (for example, instead of detecting a mouse IgG1 
anti-MAP2 primary with a goat anti-mouse IgG1-Alexa Fluor 488, simply apply a mouse 
IgG1 anti-MAP2 conjugated to Alexa Fluor 488). There are also commercially available kits 
that can covalently label even relatively small amounts of antibody with a fluorophore, as 
little as 10-20µg. These approaches can help circumvent issues of isotype availability, but 
there are some disadvantages. Aside from the additional expense and the limitation of only 
being able to visualize that antigen in one wavelength, the signal from a direct conjugate 
will not usually be as intense as with conventional secondary detection, since there hasn’t 
been an additional round of signal amplification (see section 4.5). This means that a higher 
concentration of antibody may be required to generate signals of sufficient strength, but this 
may also boost non-specific staining which poses problems, especially if the goal is to detect 
low abundance proteins. Biotinylated primary antibodies can help overcome some of these 
amplification issues – subsequent incubation of a sample labeled with a biotinylated 
primary with an avidin or streptavidin-fluorophore conjugate will boost the signal relative 
to a fluorophore-conjugated primary, but there are several issues with this system also. 
Correct blocking of avidin-binding sites using an avidin/biotin blocking kit is almost always 
required in these circumstances, and the blocking procedure may need to be further altered, 
since blocking buffers containing nonfat dry milk contain endogenous biotin, a factor that 
could prevent effective blocking and/or labeling. 
5. Fluorescence microscopy 
Fluorescent molecules are a useful and convenient means of visualizing 
protein(s)/peptide(s) of interest within a cell and therefore are widely used in ICC. 
However, fluorescence-based stainings must be interpreted with caution, since the use of 
fluorescent molecules – especially when using multiple fluorophores together – has a few 
disadvantages.  
5.1 Bleed-through 
One of the major pitfalls with fluorescence-based stainings is bleed-through. Bleed-through 
occurs when the emission wavelength of one fluorophore is detected in the emission 
detection channel of another fluorophore (Fig. 1). This can happen in either direction, i.e. 
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Fig. 1. Bleed-through of the fluorescent signal with immunofluorescence-based detection of 
voltage-gated K+ (Kv) channel subunits. In the upper row, the expression of Kv2.1 in a 
HEK293 cell has been fluorescently detected by incubating with a Kv2.1-specific antibody 
(1µg/ml; K89 from NeuroMab, UC Davis, CA, USA) followed by a green Alexa Fluor 488 
labeled goat anti-mouse IgG1 secondary antibody (1/1600 dilution, Invitrogen, San Diego, 
CA, USA). The lower row represents a HEK293 cell expressing HA-labeled Kv6.4, which 
was detected by incubating with a HA-specific antibody (4 µg/ml; 12CA5 from Roche 
Diagnostics, Basel, Switzerland) followed by a red Alexa Fluor 555 labeled goat anti-mouse 
IgG2b secondary antibody (1/1600 dilution, Invitrogen). In each row, the left, middle and 
right image represents the red, green and blue detection channel, respectively. Note the 
slight bleed-through of the green fluorescent Kv2.1 signal in the blue detection channel 
(upper row) and the more pronounced bleed-through of the red fluorescent Kv6.4-HA 
signal in the green detection channel (lower row). 
bleed-through from a shorter wavelength into a longer wavelength’s detection channel and 
vice versa. Due to bleed-through, results can be interpreted incorrectly; it can be mistakenly 
believed that the protein of interest was detected in its wavelength detection channel, when 
in reality only the emission of a fluorophore used to observe another protein was detected. 
Bleed-through can be minimized by using fluorophores where the emission wavelengths are 
widely separated from each other; when one protein of interest is detected at a shorter 
wavelength (350 nm for example) and the other protein of interest is investigated in a longer 
wavelength detection channel (650 nm for example), bleed-through of emission of one 
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wavelength in the other detection channel will not occur. However, detecting proteins in 
those shorter and longer wavelengths is only possible when the detected protein is present 
in abundance and the antibodies used are providing a strong signal, since weaker 
fluorescent signals are more difficult to observe in longer wavelengths such as 650 nm. In 
addition, the far red and infrared detection channels (i.e. 650 nm and above) are not 
especially common detection channels on most conventional fluorescent microscopes. 
Although bleed-through can happen in either direction, bleed-through usually occurs from 
a lower emission wavelength detection channel into a higher emission wavelength detection 
channel. Therefore, it may be better to start imaging with higher wavelengths and continue 
imaging toward lower wavelengths when multiple fluorphores are used to minimize bleed-
through. Bleed-through can also be minimized by minimizing the exposure time of the 
fluorophore to the lowest necessary level; minimizing the exposure time would also 
decrease the excitation of the fluorophore causing the bleed-through. If possible, the 
specificity of the emission spectrum reaching the camera/eyepieces can be increased by 
employing bandpass filters specific for the fluorophore in question rather than the less 
specific and less costly short or long-pass filters.  
5.2 Background and non-specific signals 
Another major pitfall of fluorescence-based staining is background fluorescence. This could 
be caused by autofluorescence of the sample, non-specific binding of the antibody in the 
case of immunostainings and/or non-specific excitation of another fluorophore by the 
selected excitation wavelength when multiple fluorophores are used.  Such background 
fluorescence is a particular problem when the fluorescent signal of interest is relatively 
weak. With stronger fluorescent signals of interest the microscope settings can easily be 
changed (i.e. lower laser strength and lower gain) to minimize background fluorescence. 
However, with a weaker fluorescent signal, reducing the microscope settings will mask the 
signal of interest. In this case trying to obtain a stronger fluorescent signal of interest is the 
only way to discriminate between background fluorescence and the fluorescent signal of 
interest. An increased fluorescent signal of interest can be achieved by using a primary 
antibody that exhibits less non-specific binding and/or provides a stronger signal by having 
a stronger binding affinity to the protein of interest and/or by using another detection 
channel (i.e. fluorescent signals can be easier to detect in shorter wavelengths). Since 
secondary antibodies can also exhibit non-specific binding, secondary antibodies can also 
contribute to background fluorescence. To determine whether secondary antibodies are also 
causing background fluorescence, the sample can be incubated with the secondary antibody 
alone; any remaining fluorescence is by definition background fluorescence. To avoid such 
background fluorescence, it may help to optimize the dilution of the secondary antibody, or 
switch to an alternative secondary antibody. 
5.3 Discerning the signals 
Due to limitations in microscope resolution, it is difficult to discern the presence of a few 
proteins at the plasma membrane (PM) when the majority resides in the endoplasmic 
reticulum (ER). This could be solved by making z-stack images on a confocal microscope. 
These are generated by sequentially focusing on a thin horizontal section of the cell, and 
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generating a final composite of the stack in each image. However, the cost of a confocal 
microscope is almost five times a conventional microscope and is therefore not always an 
option. Another way to determine the presence of a few proteins at the PM when the 
majority is localized in the ER is by performing surface staining prior to cell 
permeabilization. However, surface staining can also be a challenge; just a few thousand 
copies of a (trans)membrane protein such as ion channels may still have significant 
functional contributions to the cell membrane properties, but this level of expression may be 
difficult to detect using immuno-based surface staining.  
5.4 Focusing level 
To prevent misinterpretation of the results using fluorescence microscopy it is also 
important to know the level within the cell at which the microscope is focused. For example, 
the voltage-gated K+ (Kv) channel Kv2.1 demonstrates a clustered membrane staining 
pattern both natively in neurons and in heterologous expression systems (Mohapatra et al., 
2008; Scannevin et al., 1996; Vacher et al., 2008). However, this is only visible when focused 
on the cell membrane (Fig. 2, left). When the focus lays more on intracellular cell 
compartments/organelles, these Kv2.1 clusters are no longer detectable and the Kv2.1 
membrane localization is only visible as a colored ‘ring’ around the edge of the cell (Fig. 2, 
right). 
 
 
 
Fig. 2. Visualization of the plasma membrane (PM) localization of the voltage-gated K+ (Kv) 
subunit Kv2.1 depends on the level in the cell at which the microscope is focused. Both left 
and right images show a representative HEK293 cell expressing GFP-labeled Kv2.1. When 
the focus in the cell is on the PM, the clustered PM localization of Kv2.1 is readily detectable 
(left image) while the Kv2.1 PM localization is only noticeable as a colored ‘ring’ around the 
edge of the cell when the focal plane lies deeper in the cell (right image).  
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5.5 Bleaching and weakening of fluorescent signals 
A last point that has to be taken into account when using fluorescent molecules to detect 
proteins of interest is bleaching. Fluorophores are highly light sensitive and exposure of those 
fluorescent molecules to light cause bleaching of the fluorophore. Because of this, weak signals 
could disappear before detection, resulting in misinterpretation of the results. To avoid this, 
exposure of the fluorophores to light has to be minimized which includes storing the 
fluorophores in a dark place, covering the samples during incubation with fluorophore 
conjugates and minimizing the exposure of the fluorophores to light when images are taken. 
6. Alternative approaches 
Because the use of antibodies to investigate the (co-)localization of proteins experimentally 
is usually not that easy as it is in theory, it is sometimes more convenient to use genetically-
encoded fluorescent proteins to define the (sub-)cellular expression of the 
protein(s)/peptide(s) of interest and to define specific cellular compartments/organelles.  
6.1 Genetically-encoded labels 
To examine the (co-)localization of one or more proteins of interest in cells, those proteins 
can be labeled with a genetically-encoded fluorescent label, such as green fluorescent 
protein (GFP) or its yellow (YFP), cyan (CFP), blue (BFP) or red (RFP) variants, in which a 
mutation in the GFP chromophore is introduced to change the color. To obtain such 
genetically-encoded fluorescent labeled proteins, the cDNA of the fluorescent label and that 
of the protein of interest have to be cloned in frame with each other.  
The use of genetically-encoded protein labels has a few major advantages compared to the 
use of immunofluorescent detection of the protein of interest. Using genetically-encoded 
labeled proteins allows experiments to be performed in live cells, which eliminates possible 
artifacts that could occur as a result of cell fixation. In addition, this opens the opportunity 
to perform live cell imaging - in which changes in a protein’s localization can be tracked in 
real-time within the same cell. The use of genetically-encoded labeled proteins also permits 
less protein to be expressed in order to be able to visualize the protein of interest in cells, 
since the fluorescent signal of genetically-encoded labels is stronger than that of 
immunofluorescence-based stainings. For example, at least 1 µg of the plasmid containing 
the Kv channel Kv2.1 cDNA has to be transfected to observe good clustered plasma 
membrane staining when antibodies are used while only 100 ng GFP-labeled Kv2.1 has to be 
transfected to obtain a similar Kv2.1 plasma membrane staining. Because less protein has to 
be expressed, possible artifacts caused by an overload of the cell transcription/translational 
machinery are minimized. Using genetically-encoded labeled proteins also eliminate non-
specific/background staining caused by non-specific binding of the used antibodies in 
immunofluorescence-based stainings.  
As with any experimental technique, the use of genetically-encoded labeled proteins also 
has some disadvantages which have to be taken into account. GFP and its variants are 
fairly large proteins (~ 30 kDa) which are added to the protein of interest. This could 
result in changes in the native properties of the protein or in native protein-protein 
interactions. Therefore, one always has to verify that the properties of the fluorescently-
labeled fusion protein have not significantly been changed compared to the non-labeled 
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protein. In the case of ion channels, this can be easily determined based on the 
electrophysiological properties of the channels using the patch clamp technique. Even if 
the native properties of a genetically-encoded fluorescent-labeled protein have not been 
changed, such labeled proteins cannot readily be used to investigate the localization of 
native proteins in native cells (such as neurons), since those genetically-encoded labeled 
proteins always have to be transfected into cells or introduced into the animal (i.e. GFP 
knock-in mice). 
6.2 Genetically-encoded marker proteins to identify cellular compartments 
In addition to the fluorescent labels used to localize a protein of interest in live cells, 
different cellular compartments can also be identified by transfecting genetically-encoded 
fluorescent proteins. Those proteins are so modified that they are targeted to a certain 
cellular compartment using established signal sequences.  
DsRED-ER is a genetically-encoded fluorescent protein that stains the endoplasmic 
reticulum (ER) red when expressed in cells. This ER marker was produced by cloning the 
first 17 amino acids of calreticulin (the ER signal sequence) in frame with the DsRED 
sequence and adding the ER retention signal KDEL behind the DsRED sequence 
(Ottschytsch et al., 2002). Co-transfecting this ER marker with a protein of interest into cells 
can reveal whether this protein of interest is located in the ER or not, as demonstrated in 
figure 3. Co-transfection of DsRED-ER with the GFP-labeled silent Kv subunit Kv6.4 
demonstrated a maximal overlap of the green GFP staining pattern with the red DsRED-ER 
staining pattern, indicating that this Kv6.4-GFP subunit is retained in the ER. In contrast, the 
green staining pattern of Kv2.1-GFP shows minimal overlap with the DsRED-ER staining, 
indicating that this Kv2.1 channel is not localized in the ER. 
The genetically-encoded fluorescent protein mtGFP labels the mitochondria green when 
transfected into cells. This mitochondrial marker was obtained by consecutively subcloning 
the sequence encoding the N-terminal 31 amino acids of the precursor of subunit VIII of 
cytochrome c oxidase (COX8) which is an endogenous mitochondrial transmembrane 
protein and therefore acts as the mitochondrial targeting sequence, the sequence encoding 
the hemagglutinin HA1 epitope and the sequence encoding GFP in frame with each other 
(Rizutto et al., 1995). mtGFP can be used to visualize the mitochondria and to investigate 
whether a protein of interest is localized to the mitochondria or not. Figure 4 demonstrates 
this; no overlap could be observed between the red clustered membrane staining pattern of 
Kv2.1-RFP with the green staining pattern of mtGFP, indicating that this Kv channel is not 
located in the mitochondria. Mitochondria can also be visualized with the use of mtPericam 
that labels the mitochondria green after transfecting into cells. In addition, mtPericam, due 
to its Ca2+ sensitivity, can be used to investigate changes in the intracellular mitochondrial 
Ca2+ concentration; its fluorescence intensity changes with changes in intracellular 
mitochondrial Ca2+ concentrations. mtPericam is a chimeric protein consisting of 
(consecutively): the N-terminal 12 amino acid presequence of subunit IV of cytochrome c 
oxidase (COX4), M13 which is a 26 amino acid-long peptide derived from the calmodulin 
(CaM)-binding region of the skeletal muscle light-chain kinase, circularly permuted GFP 
(cpGFP) in which the N-and C-terminus of GFP are linked to each other, and CaM (Nagai et 
al., 2001).  
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Fig. 3. Localization of GFP-labeled voltage-gated K+ (Kv) channels in the endoplasmatic 
reticulum (ER) using the ER marker DsRED-ER. The upper and lower rows represent typical 
images of GFP-labeled Kv2.1 and Kv6.4 subunits in HEK293 cells. The left, middle and right 
image represent the green GFP fluorescence, the red DsRED-ER fluorescence and the 
overlay of both fluorescent signals, respectively. The green fluorescent staining pattern of 
Kv2.1-GFP demonstrates minimal overlap with the red DsRED-ER staining pattern, 
indicating that Kv2.1-GFP is not located in the ER. Kv6.4-GFP, on the other hand, is 
localized almost entirely in the ER which is noticeable in the maximal overlap of the green 
Kv6.4-GFP staining pattern with the red DsRED-ER staining pattern.  
Lck-mCherry is a genetically-encoded fluorescent protein that stains the PM red after 
transfecting into cells. This PM marker is obtained by attaching the 
myristoylation/palmitylation motif from the Lck tyrosine kinase to the N-terminus of 
mCherry (Naumann et al., 2010). After co-transfecting Lck-mCherry with a protein of 
interest, it can be determined whether this protein of interest is localized at the PM or not. In 
figure 5, the PM localization of transiently transfected Kv2.1-GFP in HEK293 cells is 
confirmed by the maximal overlap of its green PM staining pattern with the red staining 
pattern of the PM marker Lck-mCherry. In addition, Kv6.4-GFP is not located at the PM 
since no overlap between the green staining pattern of Kv6.4-GFP and the red staining 
pattern of Lck-mCherry could be detected. 
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Fig. 4. Localization of the RFP-labeled voltage-gated K+ (Kv) channel Kv2.1 in comparison to 
the mitochondria by using the mitochondrial marker mtGFP. Shown are representative 
HEK293 cells expressing Kv2.1-RFP. The left upper and left lower images represent the red 
RFP fluorescence and the green mtGFP fluorescence, respectively. The image on the right 
represents the overlay of both fluorescent signals. Note that Kv2.1-RFP (consistent with its 
efficient trafficking to the plasma membrane) is not localized in the mitochondria since no 
overlap between the red Kv2.1-RFP staining pattern and the green mtGFP staining pattern is 
observed. 
The above-mentioned genetically-encoded marker proteins for cellular compartments can be 
used in both heterologous expression systems such as HEK293 cells as well as native cells 
such as neurons by transfecting those marker proteins in the cells of interest. However, 
neurons are not as amenable to transfection as heterologous cells, and transfection could 
also change the native properties of the neuron. For this reason, using antibodies raised 
against endogenous marker proteins of a certain cellular compartment is a useful alternative 
that can be used to differentiate cellular compartments in neurons. In this case antibodies 
raised against the cis-Golgi matrix protein GM130, early endosome-associated protein EEA1, 
Calnexin and E-Cadherin could be used to indicate Golgi (Nakamura et al., 1995), 
endosomes (Mu et al., 1995), ER (Wada et al., 1991) and PM (Volk & Geiger, 1984), 
respectively. 
In addition to the genetically-encoded cellular compartment/organelles markers, there also 
exist phenotypic markers to differentiate cell types. For example, using antibodies raised 
against the endogenously expressed microtubule-associated protein 2B (MAP2B) and glial 
fibrillary acidic protein (GFAP) allow investigators to determine whether a protein of 
interest is expressed in neurons (Izant & McIntosh, 1980) or in glial cells (Raff et al., 1979), 
respectively, since it is not always that easy to discriminate neuronal from glial cells based 
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on their morphological properties alone. This is demonstrated in figure 6; Kv2.1 
(represented by green fluorescence) is expressed in rat hippocampal neurons (marked by the 
blue staining pattern of MAP2B) and not in glial cells (marked by the red staining pattern of 
GFAP). 
 
 
 
 
Fig. 5. Localization of GFP-labeled voltage-gated K+ (Kv) channels at the plasma membrane 
(PM) in HEK293 cells using the PM marker Lck-mCherry. The upper and lower rows 
represent typical images of GFP-labeled Kv2.1 and Kv6.4 subunits in HEK293 cells. The left, 
middle and right images on both rows represent the green GFP fluorescence, the red Lck-
mCherry fluorescence and the overlay of both fluorescent signals, respectively. The green 
fluorescent signal of Kv2.1-GFP demonstrates substantial overlap with the red Lck-mCherry 
signal, indicating that Kv2.1-GFP is located at the PM. Kv6.4-GFP is not localized at the PM, 
which is exemplified by the minimal overlap of the green Kv6.4-GFP signal with the red 
Lck-mCherry signal. 
6.3 Fluorescence Resonance Energy Transfer (FRET) 
ICC can tell us about co-localization of proteins/peptides of interest due to the overlap of 
different fluorescent staining patterns, but it cannot tell us if both proteins are merely 
adjacent to one another, or if their physical proximity is the result of a functional interaction. 
Fluorescence resonance energy transfer (FRET) can be used to determine both co-
localization and actual interaction between the proteins of interest (Kenworthy, 2001).  
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Fig. 6. Localization of the voltage-gated K+ (Kv) channel Kv2.1 in cultured rat hippocampal 
neurons using neuronal and glial cell marker antibodies. In the left column, the upper, 
middle and lower images represent the red GFAP fluorescence, the green Kv2.1 fluorescence 
and the blue MAP2B fluorescence, respectively. The image on the right represents the 
overlay of the three fluorescent signals. Note that Kv2.1 expression is confined to the blue 
hippocampal neuron and absent from the red glial cell processes.  
FRET, also known as Förster resonance energy transfer, is the radiation-free transmission 
of energy from a donor molecule, which is the chromophore that initially absorbs the 
energy, to an acceptor molecule, the chromophore to which the energy is subsequently 
transferred (Förster, 1948). FRET can only occur between two chromophores when the 
following criteria have been fulfilled: (i) the donor and acceptor molecule must be 
situated in a range within 10 Å (1 nm) and 100 Å (10 nm) of each other since closer 
proximity (< 10 Å) will allow several other ways of energy transfer while more distance (> 
100 Å) will prevent the radiation-free energy transmission, (ii) the donor emission 
spectrum has to have a certain spectral overlap with the acceptor absorption spectrum 
and (iii) the donor emission dipole moment has to be almost parallel with the acceptor 
absorption dipole moment. 
When FRET occurs, light emitted by the acceptor will be observed after excitation of the 
sample with the donor excitation wavelength. However, bleed-through of donor emission 
light in the acceptor emission detection channel, as well as direct excitation of the acceptor 
chromophore by the donor excitation wavelength through to overlap in the donor and 
acceptor excitation spectra could result in detecting acceptor emission light even when no 
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FRET actually takes place. Therefore, it is better to determine the occurrence of FRET based 
on changes in the donor fluorescence. FRET results in both a decrease of the donor 
fluorescence lifetime and the donor fluorescence intensity, the latter of which is more 
convenient to determine. 
Based on the donor fluorescence intensity, the efficiency with which FRET occurs can be 
determined with following equation: 
 
  1
1     
DA background
D background DA
f f
FRET x
f f paired
     
 (1) 
In which fDA represents the fluorescence intensity of the donor in the presence of the 
acceptor, fD the fluorescence intensity of the donor in the absence of the acceptor, fbackground 
the background fluorescence intensity, and pairedDA the fraction of paired donor-acceptor 
chromophores. The donor fluorescence intensity in the presence of the acceptor (fDA) is 
determined by recording the donor emission light after exciting the sample with the donor 
excitation wavelength. By eliminating the acceptor chromophore which is obtained by 
bleaching the acceptor molecule with full power acceptor excitation wavelength laser light, 
the donor fluorescence intensity in the absence of the acceptor (fD) is obtained. If FRET 
occurs, eliminating the acceptor chromophore by bleaching will result in an increase of the 
donor fluorescence intensity since the donor will no longer be able to transfer its energy to 
the acceptor molecule (Fig. 7). The background fluorescence (fbackground) is determined by 
recording the donor emission light after bleaching of the donor chromophore with full 
power donor excitation wavelength laser light. When the fraction paired donor-acceptor 
chromophores (pairedDA) cannot be determined precisely (which is mostly the case when 
both chromophores are introduced in different proteins of which the interaction is tested) 
the acceptor chromophore has to be “over expressed” in comparison to the donor 
chromophore to ensure that this fraction is 1 and that the FRET efficiency can be determined 
adequately. 
To prevent misinterpretation of the obtained results, two ratios have to be taken into 
account when determining FRET efficiencies; both the donor:acceptor intensity ratio and the 
background:signal intensity ratio have to be high enough. If the donor:acceptor intensity 
ratio is too small (<1), FRET efficiencies will be underestimated, while a high 
background:signal intensity ratio will overestimate the effective FRET efficiency. 
Not all possible chromophore pairs can be used to perform FRET experiments. A good FRET 
donor-acceptor pair must fulfill the following criteria: (i) the acceptor and donor excitation 
spectra have to be separated enough so that the acceptor chromophore has been excited 
minimally after excitation of the donor molecule, (ii) the acceptor and donor emission 
spectra have to be separated sufficiently such that the emission spectra of the donor is 
detected minimally at the acceptor emission detection wavelength and (iii) the donor 
emission and acceptor excitation spectra have to demonstrate a maximal overlap with each 
other so that the acceptor chromophore is excited by the donor’s emission wavelength after 
being excited with its own excitation wavelength. Due to these criteria, the optimal 
excitation and emission wavelength of both donor and acceptor molecule is not always at 
the maximum of their excitation and emission spectra. 
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Fig. 7. Interaction between voltage-gated K+ (Kv) subunits determined by FRET using CFP 
and YFP-labeled Kv channel constructs. (A) Representative cell expressing both N-
terminally labeled CFP-Kv6.4 and YFP-Kv2.1 subunits. The panels on the left and right 
show the CFP and YFP emission light after excitation with the CFP excitation wavelength 
(in this case 458 nm), respectively, while the top and bottom panels represent CFP and YFP 
emissions before and after bleaching of YFP in the whole cell, respectively. If FRET occurs, 
the CFP emission is underestimated since CFP transfers its emission light onto YFP which is 
relieved by eliminating YFP by bleaching with full power YFP excitation wavelength laser 
light (514 nm in this case); note the increased CFP intensity and the decreased YFP emission 
after YFP bleach. (B) Recorded emission spectra of the indicated region in panel A (red oval) 
before (black line) and after (green line) YFP bleaching. Note the increase in intensity in the 
CFP detection wavelengths (indicated by the red circle) and the significant decrease in the 
YFP detection wavelength intensity after YFP is bleached in the whole cell. Background 
signal (yellow line) was determined after fully bleaching CFP.  
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The donor-acceptor pair CFP-YFP fulfills these criteria reasonably and is therefore often 
used as a FRET donor-acceptor pair. Another good FRET donor-acceptor pair is the donor-
acceptor pair BFP-GFP (Pollok & Heim, 1999). In addition to the genetically-encoded 
chromophores, organic cyanine dyes such as Cy3 and Cy5 which act as donor and acceptor 
chromophore, respectively, are also often used to perform FRET experiments. Those dyes 
have some advantages compared to the genetically-encoded chromophores (i.e. less spectral 
overlap between the donor emission and acceptor excitation spectrum is required and larger 
distances between both chromophores are possible) but these organic cyanine dyes have to 
be chemically linked to the proteins of interest which is a great disadvantage.  
The position in which the acceptor/donor chromophore is introduced into the protein of 
interest is very important when performing FRET experiments. In addition to the fact that 
these chromophores could change the properties of the native protein significantly, it is also 
possible that those chromophores are introduced into the proteins at positions where the 
distance between both chromophores is too large to observe FRET. For example, when the 
interaction between voltage-gated K+ subunits is investigated by FRET experiments, the 
subunits have to be labeled N-terminally and not C-terminally since no FRET could be 
observed when those subunits are labeled C-terminally although those subunits physically 
interact with each other in a functional tetrameric Kv channel (Bocksteins et al., 2009; 
Kobrinsky et al., 2006).  
In addition to using FRET to investigate whether two proteins of interest only co-localize or 
actually interact with each other, FRET can also be used to ascertain whether the lack of 
functional membrane proteins at the PM is due to a trafficking or tetramerization deficiency 
(Bocksteins et al., 2009). For this purpose, the FRET efficiency in both a region that 
represents the PM and a region that represents the ER has to be determined. When a 
trafficking deficiency causes the lack of functional membrane proteins at the PM, FRET 
could still be observed in the ER while a tetramerization deficiency would also eliminate 
FRET in the ER. With this approach, it has been demonstrated that the reduced PM 
expression of mutant Kv2.1 channels was due to a tetramerization deficiency, since the 
observed reduced current amplitude of those mutant channels was accompanied by a 
significant reduction of FRET in the ER (Bocksteins et al., 2009). 
7. Conclusion 
ICC is a powerful, versatile tool for furthering our understanding of the expression, 
localization and interactions of proteins at the cellular level. This power has only been 
augmented by more recent developments in molecular biology, where insights into the 
behavior of proteins in live cells, or interactions on the atomic scale can now be investigated. 
Unfortunately, there are many ways in which the results of ICC can be sub-optimal or 
completely negative if attention isn’t paid to certain key concepts, and an understanding of 
the principles involved isn’t developed. Taking voltage-gated ion channels and neurons as 
our examples, we have explained the core principles behind the most widely-used 
techniques in ICC: how to correctly fix cells so that the structure of even complex 
transmembrane proteins will be preserved faithfully; the processes of blocking and 
permeabilization and the ways in which they can be modified to ensure the best possible 
results; the importance of the difference between monoclonal and polyclonal antibodies and 
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how the signals from antibodies of interest should be validated; as well as the dilution and 
storage conditions that will minimize the loss of antibody activity. Secondary antibody 
options were detailed, explaining the strengths and weaknesses associated with the 
common approaches to detecting primary antibody signal. Alternative strategies, which can 
enable staining that wasn’t previously possible, were outlined, as were the limitations and 
errors that are frequently encountered in fluorescence microscopy. Finally, we discussed 
approaches that can complement antibody-based studies, namely the transfection of 
fluorescent-labeled constructs targeted to specific sub-cellular compartments, and the use of 
FRET to discover if two proteins that appear in close proximity are physically interacting or 
not. The combined powers of these techniques still have a great deal to teach us across the 
life sciences as a whole, and will continue to be an integral part of studies therein for the 
foreseeable future.  
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